Charles J. Smith

3.3k total citations
73 papers, 2.5k citations indexed

About

Charles J. Smith is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charles J. Smith has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Radiology, Nuclear Medicine and Imaging, 33 papers in Oncology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charles J. Smith's work include Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (23 papers) and Prostate Cancer Treatment and Research (10 papers). Charles J. Smith is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (23 papers) and Prostate Cancer Treatment and Research (10 papers). Charles J. Smith collaborates with scholars based in United States, United Kingdom and Brazil. Charles J. Smith's co-authors include Timothy J. Hoffman, Wynn A. Volkert, Kattesh V. Katti, Gary L. Sieckman, Hariprasad Gali, Raghuraman Kannan, J. David Robertson, Nellie K. Owen, Silvia S. Jurisson and C S Rubin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Charles J. Smith

67 papers receiving 2.4k citations

Peers

Charles J. Smith
Carla J. Mathias United States
Oliver Thews Germany
C. Andrew Boswell United States
Hariprasad Gali United States
Adrian D. Nunn United States
Alan B. Packard United States
Yasushi Arano Japan
Lina He China
Hirofumi Hanaoka Japan
Thomas L. Mindt Switzerland
Carla J. Mathias United States
Charles J. Smith
Citations per year, relative to Charles J. Smith Charles J. Smith (= 1×) peers Carla J. Mathias

Countries citing papers authored by Charles J. Smith

Since Specialization
Citations

This map shows the geographic impact of Charles J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles J. Smith more than expected).

Fields of papers citing papers by Charles J. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles J. Smith. The network helps show where Charles J. Smith may publish in the future.

Co-authorship network of co-authors of Charles J. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Charles J. Smith. A scholar is included among the top collaborators of Charles J. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles J. Smith. Charles J. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Hang, Ping Yu, Charles J. Smith, et al.. (2024). Bimodal MRI/Fluorescence Nanoparticle Imaging Contrast Agent Targeting Prostate Cancer. Nanomaterials. 14(14). 1177–1177. 6 indexed citations
3.
Lewis, Michael R., Mojgan Golzy, Anupam Mathur, et al.. (2024). Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen. Nuclear Medicine and Biology. 136-137. 108938–108938. 3 indexed citations
4.
Xu, Hang, Li Lee, Ran Li, et al.. (2018). Design, Synthesis, and in Vitro and in Vivo Evaluation of High Affinity and Specificity Near-Infrared Fluorescent Bombesin Antagonists for Tumor Imaging. Journal of Medicinal Chemistry. 61(17). 7657–7670. 16 indexed citations
5.
Lewis, Michael R., et al.. (2018). Synthesis and Evaluation of [DUPA-6-Ahx-Lys (DOTA)-6-Ahx-RM2], a Novel, Bivalent Targeting Ligand for GRPr/PSMA Biomarkers of Prostate Cancer. Chemical Biology Letters. 5(1). 11–24. 2 indexed citations
6.
Bandara, Nilantha, Stephanie Krieger, Jingli Xu, et al.. (2018). Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer. Nuclear Medicine and Biology. 62-63. 71–77. 21 indexed citations
7.
Liu, Dijie, et al.. (2015). Targeted antisense radiotherapy and dose fractionation using a 177Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate. Nuclear Medicine and Biology. 42(9). 704–710. 2 indexed citations
8.
Zambre, Ajit, Nripen Chanda, Timothy J. Hoffman, et al.. (2014). Bombesin Peptide Conjugated Gold Nanocages Internalize via Clathrin Mediated Endocytosis. Bioconjugate Chemistry. 25(8). 1565–1579. 34 indexed citations
9.
10.
Liu, Dijie, Jingli Xu, Yubin Miao, et al.. (2014). Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy. Nuclear Medicine and Biology. 42(2). 99–108. 27 indexed citations
11.
Dijkgraaf, Ingrid, Gerben M. Franssen, William J. McBride, et al.. (2012). PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog. Journal of Nuclear Medicine. 53(6). 947–952. 60 indexed citations
12.
Yu, Ping, Cynthia Besch‐Williford, Charles J. Smith, et al.. (2012). Near‐infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases. The Prostate. 73(8). 842–854. 47 indexed citations
13.
Oliveira, Érica A., et al.. (2012). Comparison of two peptide radiotracers for prostate carcinoma targeting. Clinics. 67(2). 163–170. 6 indexed citations
14.
Esteves, Teresa, Fernanda Marques, António Paulo, et al.. (2011). Nuclear targeting with cell-specific multifunctional tricarbonyl M(I) (M is Re, 99mTc) complexes: synthesis, characterization, and cell studies. JBIC Journal of Biological Inorganic Chemistry. 16(8). 1141–1153. 30 indexed citations
15.
Nanda, Prasant Kumar, et al.. (2010). Radiolabeled regulatory peptides for imaging and therapy. Current Opinion in Endocrinology Diabetes and Obesity. 17(1). 69–76. 19 indexed citations
16.
Smith, Charles J., et al.. (2006). Evaluation of Combined 177 Lu-DOTA-8-AOC-BBN (7-14)NH 2 GRP Receptor-Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell Xenografted SCID Mice. Cancer Biotherapy and Radiopharmaceuticals. 21(2). 155–166. 29 indexed citations
17.
Smith, Charles J., Hariprasad Gali, Gary L. Sieckman, et al.. (2003). Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nuclear Medicine and Biology. 30(2). 101–109. 90 indexed citations
18.
Smith, Charles J., Wynn A. Volkert, & Timothy J. Hoffman. (2003). Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: A concise update. Nuclear Medicine and Biology. 30(8). 861–868. 107 indexed citations
19.
Cutler, Cathy S., et al.. (2000). Current and Potential Therapeutic Uses of Lanthanide Radioisotopes. Cancer Biotherapy and Radiopharmaceuticals. 15(6). 531–545. 73 indexed citations
20.
Smith, Charles J., C S Rubin, & O M Rosen. (1979). Insulin stimulated phosphorylation of ribosomal protein s 6 in 3t3 l 1 pre adipocytes. The Journal of Cell Biology. 83. 252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla J. Mathias Breakdown of academic impact, for papers by Oliver Thews Breakdown of academic impact, for papers by C. Andrew Boswell Breakdown of academic impact, for papers by Hariprasad Gali Breakdown of academic impact, for papers by Adrian D. Nunn Breakdown of academic impact, for papers by Alan B. Packard Breakdown of academic impact, for papers by Yasushi Arano Breakdown of academic impact, for papers by Lina He Breakdown of academic impact, for papers by Hirofumi Hanaoka Breakdown of academic impact, for papers by Thomas L. Mindt
Rankless by CCL
2026